Want to see MLSS full AI Analyst Report?
Milestone Scientific (MLSS) Stock Statistics & Valuation Metrics
Total Valuation
Milestone Scientific has a market cap or net worth of $27.61M. The enterprise value is $28.44M.
- Market Cap
- $27.61M
- Enterprise Value
- $28.44M
Share Statistics
Milestone Scientific has 90,644,400 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 90,644,400
- Owned by Insiders
- ―
- Owned by Institutions
- 0.41%
Financial Efficiency
Milestone Scientific’s return on equity (ROE) is -2.03 and return on invested capital (ROIC) is -148.63%.
- Return on Equity (ROE)
- -2.03
- Return on Assets (ROA)
- -0.73
- Return on Invested Capital (ROIC)
- -148.63%
- Return on Capital Employed (ROCE)
- -1.55
- Revenue Per Employee
- 598.27K
- Profits Per Employee
- -381.48K
- Employee Count
- 15
- Asset Turnover
- 1.15
- Inventory Turnover
- 0.70
Valuation Ratios
The current PE Ratio of Milestone Scientific is -6.39. Milestone Scientific’s PEG ratio is -0.10.
- PE Ratio
- -6.39
- PS Ratio
- 2.93
- PB Ratio
- 8.17
- Price to FCF
- -42.95
- Price to Operating Cash Flow
- -44.14
- PEG Ratio
- -0.10
Income Statement
In the last 12 months, Milestone Scientific had revenue of 8.97M and earned -5.72M in profits. Earnings per share was -0.07.
- Revenue
- 8.97M
- Gross Profit
- 6.33M
- Operating Income
- -5.70M
- Pretax Income
- -5.72M
- Net Income
- -5.72M
- EBITDA
- -5.51M
- Earnings Per Share (EPS)
- -0.07
Cash Flow
In the last 12 months, operating cash flow was -642.64K and capital expenditures 5, giving a free cash flow of -642.63K billion.
- Operating Cash Flow
- -642.64K
- Free Cash Flow
- -642.63K
- Free Cash Flow per Share
- -0.01
Dividends & Yields
Milestone Scientific pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -2.33%
- Earnings Yield
- -14.61%
Stock Price Statistics
- Beta
- 0.89
- 52-Week Price Change
- -26.75%
- 50-Day Moving Average
- 0.40
- 200-Day Moving Average
- 0.35
- Relative Strength Index (RSI)
- 31.28
- Average Volume (3m)
- 123.30K
Important Dates
Milestone Scientific upcoming earnings date is Nov 12, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 14, 2026
- Next Earnings Date
- Nov 12, 2026
- Ex-Dividend Date
- ―
Financial Position
Milestone Scientific as a current ratio of 1.81, with Debt / Equity ratio of 36.27%
- Current Ratio
- 1.81
- Quick Ratio
- 0.89
- Debt to Market Cap
- 0.04
- Net Debt to EBITDA
- 0.02
- Interest Coverage Ratio
- -222.53
Taxes
In the past 12 months, Milestone Scientific has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Milestone Scientific EV to EBITDA ratio is -6.67, with an EV/FCF ratio of -40.69.
- EV to Sales
- 2.78
- EV to EBITDA
- -6.67
- EV to Free Cash Flow
- -40.69
- EV to Operating Cash Flow
- -40.69
Balance Sheet
Milestone Scientific has $2.07M in cash and marketable securities with $615.70K in debt, giving a net cash position of $1.45M billion.
- Cash & Marketable Securities
- $2.07M
- Total Debt
- $615.70K
- Net Cash
- $1.45M
- Net Cash Per Share
- $0.02
- Tangible Book Value Per Share
- $0.04
Margins
Gross margin is 69.61%, with operating margin of -43.56%, and net profit margin of -43.98%.
- Gross Margin
- 69.61%
- Operating Margin
- -43.56%
- Pretax Margin
- -43.98%
- Net Profit Margin
- -43.98%
- EBITDA Margin
- -41.58%
- EBIT Margin
- -43.56%
Analyst Forecast
The average price target for Milestone Scientific is $1.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $1.50
- Price Target Upside
- 393.42% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 1
- Revenue Growth Forecast
- 3.72%
- EPS Growth Forecast
- 43.78%
Scores
- Smart Score
- ―
- AI Score
- 51